Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,064.00    -66.00 (-1.60%)
Bid:
4,056.00
Ask:
4,062.00
Spread: 6.00 (0.148%)
Market Cap: £4.27b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Pre-Close Trading Update

10 Jul 2008 07:00

RNS Number : 7434Y
Computacenter PLC
10 July 2008
 



Computacenter plc

Pre-Close Trading Update

Computacenter is today holding an Investor and Analyst conference call to provide an update on trading for the six months to 30 June 2008.

Group revenues for the first-half of 2008 will show growth of approximately 8%. Even after taking into consideration the benefit of a strengthening euro, the organic growth rate is the strongest for a number of years. 

Since we last reported on trading, the improved performance at our UK and French subsidiaries has continued. We are pleased to report that the Q2 2008 performance was ahead of Q1 2008, and ahead of Q2 2007 in both revenue and profit in both countries.

As we have already announced, the UK had a difficult start to 2008 and the first six weeks trading was particularly tough, however UK sales for the first six months were up 4.8% and up 8.3% in Q2. We have seen strong growth from our Software Business Unit where we believe we have gained significant market share however this does have a diluting effect on our overall gross margins.

We continue to invest heavily in our UK business to build our position in the mid-market and to increase our services capability. These investments, together with the poor start to the year will, as anticipated, result in UK first-half profitability below last year.

The improved performance in France in Q2 has meant that the first half loss will be broadly similar to H1 2007 in local currency but the positive trend in performance together with some major contract successes bodes well for the second half of 2008.

In Germany trading has been consistent throughout the first half of 2008. Revenue in local currency has fallen slightly in comparison to the first-half of 2007, however, mainly due to improved services margins, the profit growth we experienced last year has continued. 

Group debt at the end of the period will be approx £30M (2007H1: £16.5M) before customer specific financing. Good cash generation meant that before taking into account the £20.8M we have spent buying back shares since 1 July 2007 our net debt position improved by £7.3M.

We are encouraged by the Group's performance in the second quarter. Although there is much uncertainty in the market place, customers undoubtedly need to invest in information technology to increase the efficiency of their businesses, reduce risk and improve their competitiveness. We believe customers are increasingly looking to Computacenter to gain an increased value from their information technology investment.

As anticipated first-half Group pre-tax profits are expected to be lower than the same period last year. However, due to the impact of share buy backs and an improved tax position, earnings per share will show aimprovement.

Computacenter will report its Interim results on 28 August 2008.

Enquiries:

 

Computacenter plc
 
Mike Norris, Chief Executive
01707 631601
Tony Conophy, Finance Director
01707 631515
Tessa Freeman, PR Manager
01707 631514
 
 
Tulchan Communications
020 7353 4200
Andrew Grant
 
Stephen Malthouse
 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFGGGNNLZGRZM
Date   Source Headline
14th Sep 20204:15 pmRNSDirector/PDMR Shareholding
11th Sep 202011:00 amRNSDirector/PDMR Shareholding
9th Sep 20207:00 amRNSArrangement Agreement to Acquire IT Solutions Firm
9th Sep 20207:00 amRNSHalf-year Report
2nd Sep 20207:00 amRNSTrading Statement
6th Aug 20201:15 pmRNSBlock listing Interim Review
22nd Jul 20207:00 amRNSH1 2020 Trading Statement
15th May 20207:00 amRNSTrading Statement
14th May 20202:00 pmRNSResult of AGM
30th Apr 20205:00 pmRNSDirector/PDMR Shareholding
27th Apr 20203:31 pmRNSDisclosure of Rights Attaching to Equity Shares
27th Apr 202011:21 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSQ1 2020 Trading Update
9th Apr 20207:00 amRNS2019 Annual Report & Notice of 2020 AGM
6th Apr 20205:45 pmRNSDirector Remuneration
3rd Apr 20207:00 amRNSDirector Declaration
25th Mar 20205:00 pmRNSDirector/PDMR Shareholding
25th Mar 20204:45 pmRNSDirector/PDMR Shareholding
24th Mar 20202:00 pmRNSDirector Declaration
24th Mar 20209:00 amRNSAcquisition
12th Mar 20207:00 amRNSFinal Results 2019
6th Feb 20209:31 amRNSBlock listing Interim Review
23rd Jan 20207:00 amRNSPre-Close Trading Statement
17th Dec 201910:15 amRNSDirector/PDMR Shareholding
13th Dec 201910:16 amRNSNotification of Major Interest in Shares
10th Dec 20197:00 amRNSTrading Statement
4th Dec 201911:01 amRNSDirector/PDMR Shareholding
3rd Dec 20199:17 amRNSDirector/PDMR Shareholding
1st Nov 20197:00 amRNSNotification of Major Interest in Shares
30th Oct 20197:00 amRNSQ3 2019 Trading Update
23rd Oct 20193:45 pmRNSDirector/PDMR Shareholding
29th Aug 20194:30 pmRNSNotification of Major Interest in Shares
28th Aug 201910:26 amRNSDirector/PDMR Shareholding
23rd Aug 20197:00 amRNSHalf-year Report
20th Aug 20194:30 pmRNSDirectorate Change
14th Aug 20195:06 pmRNSNotification of Major Interest in Shares
6th Aug 201910:33 amRNSBlock listing Interim Review
1st Aug 20194:39 pmRNSNotification of Major Interest in Shares
31st Jul 20197:00 amRNSH1 2019 Trading Statement
29th May 20196:00 pmRNSDirector/PDMR Shareholding
16th May 20196:00 pmRNSDirectorate Change
16th May 201911:00 amRNSDirectorate Change
16th May 201910:00 amRNSResult of AGM
9th May 20195:30 pmRNSDirector/PDMR Shareholding
26th Apr 20197:00 amRNSQ1 2019 Trading Update
17th Apr 20199:45 amRNSDirector/PDMR Shareholding
12th Apr 20197:00 amRNS2018 Annual Report & Notice of 2019 AGM
4th Apr 20199:45 amRNSDirector Declaration
25th Mar 20194:30 pmRNSDirector/PDMR Shareholding
25th Mar 201912:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.